The first important results with a new drug under development by Isis Pharmaceuticals may well have an enormous long term impact on our understanding of how blood flows through the body and how that same blood forms clots in response to damage and disease. But it appears unlikely that the new drug– an anticoagulant unlike anything…
New Drug From Isis Breaks Important Ground But Unlikely To Dent The Market
December 7, 2014 by Leave a Comment
Physicians Report Alarming Increase In LVAD Pump Thrombosis
November 27, 2013 by Leave a Comment
Physicians from three top institutions report an abrupt and highly troubling increase over the last two years in the incidence of pump thrombosis in patients who have received the HeartMate II left ventricular assist device (LVAD) manufactured by Thoractec. The current investigation, published online in the New England Journal of Medicine, was initially prompted by an observed increase in…
Recent Comments